Cancel
Karen S. Ho, PhD
Vice President, Translational Medicine
@
Clene Nanomedicine
3794j@vt73y.1qp
Sign up to see email
Known information
- Received a BS in Biochemistry summa cum laude from Washington University as a Compton Scholar
- Earned a MS in Genetics from the University of Cambridge as a Marshall Scholar
- Has a PhD in Developmental Biology from Stanford
- Completed postdoctoral training as a National Sleep Foundation Pickwick Scholar and Howard Hughes Medical Institute Postdoctoral Fellow at University of Pennsylvania in the Department of Neuroscience
- Serves on several rare disease group Scientific Advisory Boards
- Holds a concurrent position as adjunct faculty at the University of Utah School of Medicine in the Department of Pediatrics, Division of Medical Genetics
- Was the lead scientist at a startup diagnostic testing company, where she streamlined and innovated new methodologies for the scientific interpretation of genetic testing results for children with autism, developmental delays, and/or cognitive impairment
About Clene Nanomedicine
Clene Nanomedicine is a biopharmaceutical company focused on developing nanotherapeutics for neurodegenerative diseases, with its lead candidate, CNM-Au8, targeting ALS, MS, and Parkinson's Disease.
Report inaccurate information
